Curated News
By: NewsRamp Editorial Staff
July 08, 2026
Insurance Confirmed for TMS and Spravato at Scottsdale TMS Therapy
TLDR
- Scottsdale TMS Therapy now accepts Cigna, Aetna, and UMR, reducing out-of-pocket costs for TMS and Spravato treatments.
- Insurance verification for TMS and Spravato is confirmed; treatments use magnetic pulses or esketamine to stimulate mood-regulating brain regions.
- By covering TMS and Spravato under major insurance, Scottsdale TMS Therapy removes financial barriers for those with treatment-resistant depression.
- Spravato, an FDA-approved nasal spray, can provide relief from depression within days rather than weeks under medical supervision.
Impact - Why it Matters
This news matters because it addresses a critical barrier in mental health care: affordability. Treatment-resistant depression, anxiety, and OCD affect millions, but high out-of-pocket costs often delay or prevent access to advanced therapies like TMS and Spravato. By confirming coverage with major insurers such as Cigna, Aetna, and UMR, Scottsdale TMS Therapy makes these effective treatments financially accessible to more patients, potentially improving outcomes for those who have not responded to traditional medications. This move sets a precedent for integrating innovative psychiatric care into standard insurance frameworks, reducing the financial burden on patients and families while expanding treatment options in the community.
Summary
Scottsdale TMS Therapy has confirmed the integration of major national insurance plans—including Cigna, Aetna, and UMR—into its coverage verification framework, removing a significant financial barrier for patients seeking advanced mental health treatments. For individuals managing treatment-resistant depression, anxiety, or obsessive-compulsive disorder (OCD), the newly confirmed insurance relationships ensure that out-of-pocket costs are lowered, making care more accessible. The clinic's spokesperson emphasized that finding an effective treatment is only half the battle; the other half is affordability. By confirming coverage with these networks, Scottsdale TMS Therapy provides a clear, predictable financial path for adults and young adults across the region.
The verified insurance benefits apply directly to the clinic's specialized offerings, including Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive treatment using pulsed magnetic fields to stimulate mood-regulating brain regions. TMS is ideal for patients seeking a drug-free option, with a standard course of 30 to 36 sessions lasting 30 minutes each. Also covered is Spravato (Esketamine) Nasal Spray, an FDA-approved treatment that targets distinct brain pathways for rapid relief, administered under medical supervision following strict REMS safety requirements. Additionally, Psychiatric Medication Management is included, offering thorough evaluations and individualized treatment plans by board-certified psychiatrists and nurse practitioners to optimize prescriptions and minimize side effects.
The clinic provides a cohesive, multi-disciplinary approach with an in-house team of licensed psychiatrists, mental health nurse practitioners, therapists, and certified TMS technicians. Patients can also incorporate psychotherapy from master's-level counselors. The facility is designed for comfort, with calming aesthetics and relaxing music to ease patients throughout their therapy. For more information or to complete a confidential insurance verification, visit scottsdaletmstherapy.com.
Source Statement
This curated news summary relied on content disributed by Press Services. Read the original source here, Insurance Confirmed for TMS and Spravato at Scottsdale TMS Therapy
